-+ 0.00%
-+ 0.00%
-+ 0.00%

Annovis Bio Plans Three Presentations at CTAD Conference

PUBT·10/22/2026 12:10:23
Listen to the news
Annovis Bio Plans Three Presentations at CTAD Conference
  • Annovis Bio will deliver three presentations at the Clinical Trials on Alzheimer's Disease conference in Boston, Nov. 16-19, 2026.
  • An oral presentation on buntanetap's mechanism of action is scheduled for Nov. 19 at 3:52 p.m. ET.
  • Posters cover buntanetap's pivotal early Alzheimer's study and AI-based drug evaluation, displayed Nov. 16, 2 p.m., through Nov. 17, 5:30 p.m. ET.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Annovis Bio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610220800PRIMZONEFULLFEED9850988) on October 22, 2026, and is solely responsible for the information contained therein.